Article Information
History
- July 1, 2022.
Article Versions
- Version 1 (August 2, 2021 - 09:04).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Julia Greissla,
- Mitch Peseskyb,
- Sudeb C. Dalaib,c,*,
- Alison W. Rebmand,
- Mark J. Soloskid,
- Elizabeth J. Horne,
- Jennifer N. Dinesb,*,
- Darcy B. Gillb,
- Rachel M. Gittelmanb,*,
- Thomas M. Snyderb,
- Ryan O. Emersonb,*,
- Edward Meedsa,
- Thomas Manleyb,*,
- Ian M. Kaplanb,*,
- Lance Baldob,*,
- Jonathan M. Carlsona,
- Harlan S. Robinsb and
- John N. Aucottd,#
- aMicrosoft Research; Redmond, Washington, USA, and Cambridge, UK.
- bAdaptive Biotechnologies; Seattle, Washington, USA.
- cStanford University School of Medicine; Stanford, California, USA.
- dLyme Disease Research Center, Division of Rheumatology, Department of Medicine, Johns Hopkins University School of Medicine; Baltimore, Maryland, USA.
- eLyme Disease Biobank; Portland, Oregon, USA.
- ↵#Address correspondence to John N. Aucott, jaucott2{at}jhmi.edu
Julia Greissl and Mitch Pesesky contributed equally to this work. Jonathan M. Carlson, Harlan S. Robins, and John N. Aucott contributed equally to the oversight of this study. Author order was determined by mutual agreement.